Skip to main content

Advertisement

Log in

The effect of subtotal thyroidectomy on Graves' ophthalmopathy

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Nineteen unselected patients undergoing subtotal thyroidectomy (STT) for Graves' disease were submitted to thorough ophthalmologic assessment before and after (mean, 10 mo) thyroid surgery. All clinical examinations were performed by the same observer and findings were scored according to the American Thyroid Association (“NOSPECS”) classification. Orbital computed tomography (CT) scans were performed in all patients prior to surgery and again at follow-up if the initial scan was abnormal or if there was evidence of clinical deterioration; all CT scans were viewed by the same individual. There was evidence of infiltrative ophthalmopathy at some stage in the course of observation in 17 (89%) of the 19 patients.

No predictable ocular response to STT was apparent. Ophthalmic status was noted to improve in 6 patients, to remain unchanged in 7 patients, and to progressively deteriorate in 6 patients. This unpredictable pattern was seen irrespective of the severity of preexisting ocular involvement. The absence of any consistent or predictable ocular response to STT strongly suggests that thyroidectomy does not influence the natural course of Graves' ophthalmopathy. We believe that the presence of evolving or stable ophthalmopathy, even if severe, should not be regarded as a contraindication to STT in Graves' disease.

Résumé

Dix-neuf patients non sélectionnés ont eu une évaluation ophthalmologique avant et après (moyenne, 10 mois) une thyroïdectomie subtotale (TST) pour maladie de Basedow. Tous les examens ont été faits par le même médecin, et les résultats ont été notés selon la classification “NOSPECS” de l'American Thyroid Association. Une tomodensitométrie (TDM) orbitale a été effectuée chez tous les patients avant la thyroïdectomie et une fois encore après si l'examen initial était anormal, ou si l'état clinique s'aggravait. Tous les résultats de TDM orbitale ont été interprétés par le même médecin. Dix-sept (89%) des 19 patients avaient une ophtalmopathie infiltrative à un moment donné de l'évolution.

On n'a pas mis en évidence de réponse oculaire à la TST. L'état ophtalmique s'est amélioré chez 6 patients, est resté inchangé chez 7, et s'est détérioré chez les 6 autres. L'évolution ophtalmique était imprévisible quelle que soit la sévérité de l'état ophtalmique préexistant. L'absence de réponse oculaire constante ou prévisible dans cette série suggère fortement que la thyroïdectomie n'influe pas sur l'évolution naturelle de l'ophtalmopathie de la maladie de Basedow. Nous croyons que la présence d'ophtalmopathie, stable ou pas, même si elle est sévère, ne devrait pas constituer une contre-indication à la TST dans la maladie de Basedow.

Resumen

Diecinueve patientes no seleccionados sometidos a tiroidectomía subtotal (TST) por enfermedad de Graves fueron llevados a una completa valoración oftalmológica antes y después (promedio, 10 meses) de la cirugía tiroidea. Todos los exámenes clínicos fueron realizados por el mismo observador y los hallazgos fueron registrados de acuerdo con la clasificación de la Asociación Americana de Tiroides (“NOSPECS”). Se hicieron tomografías computadorizadas (TC) orbitales en todos los pacientes antes de la cirugía y en el período de seguimiento si la escanografía inicial era anormal o si había evidencia de deterioro clínico; todas las TC fueron interpretadas por la misma persona. Se halló evidencia de oftalmopatía infiltrativa en algún momento en el curso de la observación en 17 (89%) de los 19 pacientes.

Ninguna respuesta ocular predecible a la TST se hizo aparente. El estado oftálmico mejoró en 6 pacientes, permaneció sin cambio en 7, y se deterioró en forma progresiva en 6. Este impredecible patrón fue observado con independencia de la gravedad de la afección ocular preexistente. La ausencia de una respuesta ocular predecible o consistente a la TST ciertamente sugiere que la tiroidectomía no influencia la evolutión natural de la oftalmopatía de Graves. Creemos que la presencia de una oftalmopatía estable o en evolución, aún si es severa, no debe ser considerada como contraindicatión para la TST en la enfermedad de Graves.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Naffziger, H.C.: Progressive exophthalmos following thyroidectomy; its pathology and treatment. Ann. Surg.94:582, 1931

    Google Scholar 

  2. Means, J.H.: The nature of Graves' disease with special reference to its ophthalmic component. Am. J. Med. Sci.207:1, 1944

    Google Scholar 

  3. McGill, D.A., Asper, S.P.: Endocrine exophthalmos. A review and a report on autoantibody studies. N. Engl. J. Med.267:188, 1962

    Google Scholar 

  4. Gott, P.H.: Treatment of Graves' disease. (Letter). J.A.M.A.244:1558, 1980

    Google Scholar 

  5. Soley, M.H.: Exophthalmos in patients with various types of goiter. Arch. Intern. Med.70:206, 1942

    Google Scholar 

  6. Dobyns, B.M.: The influence of thyroidectomy on the prominence of the eyes in the guinea pig and in man. Surg. Gynecol. Obstet.80:526, 1945

    Google Scholar 

  7. Dobyns, M., Haines, S.F.: Changes in the prominence of the eyes in various thyroid states. J. Clin. Endocrinol.6:633, 1946

    Google Scholar 

  8. Lamberg, B.-A.: The thyro-hypophysial syndrome. I. The primary reaction of the hypophysial eye signs (including exophthalmos) to the treatment of thyrotoxicosis. Acta Med. Scand.148:225, 1954

    Google Scholar 

  9. Catz, B., Perzik, S.L.: Subtotal vs. total surgical ablation of the thyroid, malignant exophthalmos and its relation to remnant thyroid. In Current Topics in Thyroid Research, C. Cassano, M. Andreoli, editors, New York, Academic Press, 1965

    Google Scholar 

  10. Kirmse, L., Lahrtz, H., Schemmel, K., Waschulzik, G., Muller, W., Uthgenannt, H., Weissbecker, L.: Treatment of progressive malignant exophthalmos by total thyroidectomy. Acta Endocrinol.173:[Supp.]:24, 1973

    Google Scholar 

  11. Perzik, S.L.: Total thyroidectomy in Graves' disease in children. J. Pediatr. Surg.11:191, 1976

    Google Scholar 

  12. Bauer, F.K., Catz, B.: Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol.51:15, 1966

    Google Scholar 

  13. White, I.L.: Total thyroid ablation: A prerequisite to orbital decompression for Graves' disease ophthalmopathy. Laryngoscope84:1869, 1974

    Google Scholar 

  14. Muller, W., Schemmel, K., Uthgenannt, H., Weissbecker, L.: Die behandlung des malignen exophthalmus durch totale thyreoidektomie. Dtsch. Med. Wochenschr.46:2103, 1967

    Google Scholar 

  15. Rundle, F.F., Wilson, C.W.: Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin. Sci.5:177, 1944

    Google Scholar 

  16. Hales, I.B., Rundle, F.F.: Ocular changes in Graves' disease. A long-term follow-up study. Q. J. Med.29:113, 1960

    Google Scholar 

  17. Hamilton, R.D., Mayberry, W.E., McConahey, W.M., Hanson, K.C.: Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodide. Mayo Clin. Proc.42:812, 1967

    Google Scholar 

  18. Ingbar, S.H., Woeder, K.A.: The thyroid gland. In Textbook of Endocrinology, R.H. Williams, editor, Philadelphia, W.B. Saunders, 1981, pp. 200–201

    Google Scholar 

  19. Werner, S.C.: Modification of the classification of the eye changes of Graves' disease: Recommendations of the ad hoc committee of the American Thyroid Association (Letter). J. Clin. Endocrinol. Metab.44:203, 1977

    Google Scholar 

  20. Werner, S.C., Feind, C.R., Aida, M.: Graves' disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long-acting thyroid stimulator after operation. N. Engl. J. Med.276:132, 1967

    Google Scholar 

  21. Beierwaltes, W.H.: Exophthalmos and thiouracil therapy. Arch. Intern. Med.81:364, 1948

    Google Scholar 

  22. Duke-Elder, S., MacFaul, P.A.: Orbital involvement in general disease. In System of Ophthalmology, vol. 13, no. 2, S. Duke-Elder, editor, London, Henry Kimpton, 1974

    Google Scholar 

  23. Gwinup, G., Elias, A.N., Ascher, M.S.: Effect on exophthalmos of various methods of treatment of Graves' disease. J.A.M.A.247:2135, 1982

    Google Scholar 

  24. Pequegnat, E.P., Wayberry, W.E., McConahey, W.M., Wyse, E.P.: Large doses of radioiodide in Graves' disease: Effect on ophthalmopathy and long-acting thyroid stimulator. Mayo Clin. Proc.42:802, 1967

    Google Scholar 

  25. Jones, D.I.R., Munro, D.S., Wilson, G.M.: Observations on the course of exophthalmos after I-131 therapy. Proc. R. Soc. Med.62:15, 1969

    Google Scholar 

  26. Stockigt, J.R., Topliss, D.J.: Diagnosis and management of hyperthyroidism. Med. J. Aust.145:218, 1986

    Google Scholar 

  27. Gorman, C.A.: Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin. Proc.58:515, 1983

    Google Scholar 

  28. Agapitos, P.J., Hart, I.R.: Long-term follow-up of ophthalmic Graves' disease. Can. Med. Assoc. J.136:369, 1987

    Google Scholar 

  29. Solomon, D.H., Chopra, I.J., Chopra, U., Smith, F.J.: Identification of subgroups of Graves' ophthalmopathy. N. Engl. J. Med.296:181, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levitt, M.D., Edis, A.J., Agnello, R. et al. The effect of subtotal thyroidectomy on Graves' ophthalmopathy. World J. Surg. 12, 593–596 (1988). https://doi.org/10.1007/BF01655858

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01655858

Keywords

Navigation